Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 03, 2024

SELL
$262.75 - $319.31 $132,163 - $160,612
-503 Reduced 41.4%
712 $222,000
Q1 2024

Apr 01, 2024

SELL
$268.87 - $324.56 $58,613 - $70,754
-218 Reduced 15.21%
1,215 $345,000
Q4 2023

Jan 02, 2024

SELL
$255.7 - $288.46 $30,172 - $34,038
-118 Reduced 7.61%
1,433 $412,000
Q3 2023

Oct 12, 2023

BUY
$218.65 - $271.46 $874 - $1,085
4 Added 0.26%
1,551 $416,000
Q2 2023

Jul 03, 2023

SELL
$214.27 - $253.37 $642 - $760
-3 Reduced 0.19%
1,547 $343,000
Q1 2023

Apr 03, 2023

SELL
$225.79 - $275.2 $6,096 - $7,430
-27 Reduced 1.71%
1,550 $374,000
Q4 2022

Jan 03, 2023

BUY
$229.03 - $291.01 $361,180 - $458,922
1,577 New
1,577 $414,000
Q3 2022

Oct 04, 2022

SELL
$224.46 - $253.15 $186,750 - $210,620
-832 Closed
0 $0
Q2 2022

Jul 01, 2022

SELL
$230.71 - $256.74 $1,153 - $1,283
-5 Reduced 0.6%
832 $202,000
Q1 2022

Apr 04, 2022

SELL
$219.27 - $242.57 $22,146 - $24,499
-101 Reduced 10.77%
837 $203,000
Q4 2021

Jan 03, 2022

SELL
$198.88 - $227.6 $19,888 - $22,760
-100 Reduced 9.63%
938 $211,000
Q3 2021

Oct 01, 2021

SELL
$212.27 - $248.7 $2,547 - $2,984
-12 Reduced 1.14%
1,038 $221,000
Q1 2021

Apr 05, 2021

SELL
$221.91 - $258.6 $887 - $1,034
-4 Reduced 0.38%
1,050 $261,000
Q4 2020

Jan 05, 2021

SELL
$216.38 - $257.67 $8,006 - $9,533
-37 Reduced 3.39%
1,054 $243,000
Q3 2020

Oct 02, 2020

SELL
$234.65 - $260.95 $4,458 - $4,958
-19 Reduced 1.71%
1,091 $278,000
Q2 2020

Jul 02, 2020

SELL
$197.81 - $242.74 $4,351 - $5,340
-22 Reduced 1.94%
1,110 $262,000
Q1 2020

Apr 01, 2020

SELL
$182.24 - $241.7 $4,920 - $6,525
-27 Reduced 2.33%
1,132 $230,000
Q4 2019

Jan 03, 2020

SELL
$189.21 - $243.2 $21,002 - $26,995
-111 Reduced 8.74%
1,159 $280,000
Q3 2019

Oct 04, 2019

SELL
$174.11 - $208.62 $10,794 - $12,934
-62 Reduced 4.65%
1,270 $245,000
Q2 2019

Jul 01, 2019

SELL
$166.7 - $195.41 $13,336 - $15,632
-80 Reduced 5.67%
1,332 $245,000
Q1 2019

Apr 02, 2019

SELL
$180.87 - $203.88 $4,521 - $5,097
-25 Reduced 1.74%
1,412 $268,000
Q4 2018

Jan 03, 2019

SELL
$178.4 - $208.25 $102,044 - $119,119
-572 Reduced 28.47%
1,437 $280,000
Q3 2018

Oct 03, 2018

SELL
$185.29 - $208.89 $17,231 - $19,426
-93 Reduced 4.42%
2,009 $416,000
Q2 2018

Jul 05, 2018

BUY
$166.05 - $186.51 $112,249 - $126,080
676 Added 47.41%
2,102 $388,000
Q1 2018

Apr 04, 2018

BUY
$169.43 - $198.0 $241,607 - $282,348
1,426 New
1,426 $243,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track First Financial Bank Trust Division Portfolio

Follow First Financial Bank Trust Division and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Financial Bank Trust Division, based on Form 13F filings with the SEC.

News

Stay updated on First Financial Bank Trust Division with notifications on news.